Paul Andrews Mh ND Clinical is categorized under Blood Related Health Services in Monterey, CA and active since 1982.
Paul Andrews Mh ND Clinical was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Blood Related Health Services business, which does work in the B2C market, and is classified as a Blood Related Health Services, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Paul Andrews at the company’s single location by writing to 899 Johnson St, Monterey, California CA 93940 or by phoning (831) 646-8929. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Paul Andrews Mh ND Clinical |
| Contact Person: | Paul Andrews |
| Address: | 899 Johnson St, Monterey, California 93940 |
| Phone Number: | (831) 646-8929 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Blood Related Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 6219992 |
| Share This Business: |
Paul Andrews Mh ND Clinical was started in 1982 to provide professional Blood Related Health Services under the SIC code 8099 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Paul Andrews for inquiries that concern Paul Andrews Mh ND Clinical by calling the company number (831) 646-8929, as your correspondence is most welcome. Additionally, the physical location of the single location of Paul Andrews Mh ND Clinical can be found at the coordinates 36.601316,-121.90083 as well as the street address 899 Johnson St in Monterey, California 93940.
For its online presence, you may visit Paul Andrews Mh ND Clinical’s website at and engage with its social media outlets through on Twitter and on Facebook.